Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Factors Predicting Gvhd Free, Relapse Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation; A Multivariable Analysis of 531 Allografts from a Single Center

Melhem Solh, MD, Xu Zhang, PhD, Katelin Connor, Stacey Brown, B.A., H. Kent Holland, MD, Lawrence E. Morris, MD, Scott R. Solomon, MD, Asad Bashey, MD PhD

Blood (2015) 126 (23): 2028.

https://doi.org/10.1182/blood.V126.23.2028.2028

Published: 2015

Journal Articles

TBI-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients without Matched Sibling Donors

Scott R. Solomon, MD, Connie Sizemore, PharmD, Xu Zhang, PhD, Stacey Brown, B.A., Katelin Connor, B.S., Lawrence E. Morris, MD, H. Kent Holland, MD, Asad Bashey, MD PhD

Blood (2014) 124 (21): 426.

https://doi.org/10.1182/blood.V124.21.426.426

Published: 2014

Journal Articles

BMT Doubles The Lifespan Of A Mouse Model Of Farber Disease and Corrects Hematopoietic Defects

Shaalee Dworski, MSc, Alexandra Berger, PhD, Caren Furlonger, Christopher J. Paige, PhD, Jeffrey A. Medin, PhD

Blood (2013) 122 (21): 1997.

https://doi.org/10.1182/blood.V122.21.1997.1997

Published: 2013

Journal Articles

Systemic Ceramide Accumulation Causes Dysregulated Hematopoiesis

Shaalee Dworski, MSc, Alexandra Berger, PhD, Makoto Yoshimitsu, MD PhD, Abdulfatah Alayoubi, MBBS, Bryan Au, MSc, Mathilde Exertier, Jessa Forster, Caren Furlonger, James C Wang, MSc, Toshihiro Takenaka, MD PhD, Christopher J. Paige, PhD, Jeffrey A. Medin, PhD

Blood (2012) 120 (21): 3461.

https://doi.org/10.1182/blood.V120.21.3461.3461

Published: 2012

Journal Articles

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Eray Goekkurt, MD, Jan Stoehlmacher, MD, Christian Stueber, Christine Wolschke, MD, Tatjana Zabelina, MD, Thomas Eiermann, MD, Thomas Binder, MD, Simona Iacobelli, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2005) 106 (11): 2730.

https://doi.org/10.1182/blood.V106.11.2730.2730

Published: 2005

NARROW

Factors Predicting Gvhd Free, Relapse Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation; A Multivariable Analysis of 531 Allografts from a Single Center

TBI-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients without Matched Sibling Donors

BMT Doubles The Lifespan Of A Mouse Model Of Farber Disease and Corrects Hematopoietic Defects

Systemic Ceramide Accumulation Causes Dysregulated Hematopoiesis

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Email alerts

ASH Publications

American Society of Hematology

Factors Predicting Gvhd Free, Relapse Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation; A Multivariable Analysis of 531 Allografts from a Single Center

TBI-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients without Matched Sibling Donors

BMT Doubles The Lifespan Of A Mouse Model Of Farber Disease and Corrects Hematopoietic Defects

Systemic Ceramide Accumulation Causes Dysregulated Hematopoiesis

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only